Home/Filings/4/A/0001019687-15-001247
4/A//SEC Filing

Medytox Solutions, Inc. 4/A

Accession 0001019687-15-001247

CIK 0001374536operating

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 10:40 AM ET

Size

15.3 KB

Accession

0001019687-15-001247

Insider Transaction Report

Form 4/AAmended
Period: 2013-02-05
Hollis Sharon Lynne
VP of Operations10% Owner
Transactions
  • Gift

    Common Stock

    2013-02-054,500,0000 total
  • Other

    Common Stock

    2013-02-084,500,0000 total(indirect: See note)
  • Gift

    Series B Non-Convertible Preferred Stock

    2013-02-05+1,0001,000 total(indirect: By Aella Ltd.)
  • Other

    Series B Non-Convertible Preferred Stock

    2013-02-081,0000 total(indirect: See note)
  • Gift

    Common Stock

    2013-02-05+4,500,0004,500,000 total(indirect: By Aella Ltd.)
  • Gift

    Series B Non-Convertible Preferred Stock

    2013-02-051,0000 total
Footnotes (3)
  • [F1]This Form 4 amends these transactions which were previously reported with an incorrect transaction date of September 27, 2013. As previously reported, the 4,500,000 shares of the Issuer's Common Stock were distributed by the Reporting Person to Aella Ltd., and as of February 5, 2013 were indirectly owned by the Reporting Person. On February 5, 2013, the Reporting Person was the sole owner of Aella Ltd., and disclaims beneficial ownership of the reported securities, except to the extent of her pecuniary interest therein.
  • [F2]On February 8, 2013, the Reporting Person distributed all of the capital stock of Aella Ltd. to The Olive Tree Trust. P. Wilhelm F. Toothe is the trustee of The Olive Tree Trust. The Reporting Person is the settlor and the Reporting Person and her family are the beneficiaries of The Olive Tree Trust. As a consequence of the distribution of all of the capital stock of Aella Ltd. to The Olive Tree Trust, the Reporting Person is no longer a beneficial owner of the Issuer's Common Stock and the Issuer's Series B Non-Convertible Preferred Stock owned of record by Aella Ltd. pursuant to Section 16(a) of the Securities Exchange Act of 1934.
  • [F3]The 1,000 shares of the Issuer's Series B Non-Convertible Preferred Stock were distributed by the Reporting Person to Aella Ltd., and as of February 5, 2013 were indirectly owned by the Reporting Person. On February 5, 2013, the Reporting Person was the sole owner of Aella Ltd., and disclaims beneficial ownership of the reported securities, except to the extent of her pecuniary interest therein.

Issuer

Medytox Solutions, Inc.

CIK 0001374536

Entity typeoperating

Related Parties

1
  • filerCIK 0001374536

Filing Metadata

Form type
4/A
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 10:40 AM ET
Size
15.3 KB